Report Code : CVMI2412263 | Published Date : March 3, 2025
The global Aquaculture Vaccines Market was valued at 1.8 billion in 2023 and is projected to reach 4.2 billion by 2031, growing at a CAGR of 11.2%. Rising seafood demand, antibiotic reduction policies, and novel vaccine technologies are driving growth.
2024 Market Breakthroughs
- mRNA Vaccines for Fish:
- Elanco's NAVETCOVAC protects against Tilapia Lake Virus (TiLV) with 95% efficacy.
- Benchmark's CleanTreat® enables delivery of mRNA through water (no injections).
- Oral Delivery Innovations:
- PHARMAQ's MicroSphere oral vaccine withstands stomach acid to stimulate gut immunity.
- Vaxxinova's BioOral uses yeast carriers for three times longer protection compared to traditional vaccines.
- Climate-Resistant Formulations:
- Hipra's Thermostable VHS vaccine maintains potency at 30°C for 6 months.
- KBNP's Immersion Vaccine works in both fresh and saltwater conditions.
Market Drivers
1. Antibiotic Reduction Mandates
- EU bans prophylactic antibiotics in aquaculture (2024).
- Vietnam's new regulations require that 80% of shrimp farms be vaccinated by 2025.
2. Disease Burden
- Infectious Salmon Anemia (ISA) causes annual losses exceeding USD 1 billion.
- White Spot Syndrome Virus (WSSV) devastates entire shrimp harvests in just 72 hours.
3. Production Intensification
- Salmon farming density up 40% since 2020, increasing outbreak risks.
- Asia-Pacific shrimp production to grow 25% by 2026 (FAO).
Competitive Landscape
Company |
Market Share |
Flagship Product |
Strategic Edge |
Zoetis |
30% |
AlphaJect® vaccines |
Salmon market leader |
PHARMAQ (Merck) |
25% |
Norvax® line |
Oral delivery expertise |
Vaxxinova |
20% |
BioOral platform |
Yeast-vectored vaccines |
Emerging Disruptors:
- AquaBounty Technologies: DNA vaccines for GM salmon (FDA-approved).
- ViAqua Therapeutics: RNAi-based shrimp vaccines (Series B: USD 35M).
Market Segmentation
- By Species:
- Salmon (45%): Highest value segment.
- Shrimp (XX%): Fastest-growing (15% CAGR).
- Tilapia (XX%): Emerging mRNA adoption.
- By Technology:
- Inactivated (50%): Current standard.
- mRNA (XX%): Projected 25% CAGR through 2031.
- By Region:
- Europe (40%): Norway leads salmon vaccination.
- Asia-Pacific (XX%): Vietnam/India shrimp focus.
- Americas (XX%): Chilean salmon farms.
Recent Developments (2024)
- March 2024: Elanco's TiLV vaccine approved in Indonesia and Brazil.
- June 2024: Vietnam mandates WSSV vaccination for all export shrimp.
Reasons To Buy

Scope

Key Players
- Aquaculture Vaccines Market – Zoetis Inc.
- Merck & Co. Inc.
- Elanco Animal Health
- Virbac
- HIPRA
- Phibro Animal Health Corporation
- Benchmark Holdings plc
- Kyoritsu Seiyaku Corporation
- Vaxxinova International BV
- IDT Biologika GmbH.
Global Aquaculture Vaccines Market Report
- 1. Global Aquaculture Vaccines Market Research Report
- 1.1 Study Objectives
- 1.2 Global Aquaculture Vaccines Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Aquaculture Vaccines Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Vaccine Type
- 2.1.2 By Application
- 2.1.3 By End-user
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Vaccine Type, By Application, By End-user, By Country
- 3.3. Opportunities – By Vaccine Type, By Application, By End-user, By Country
- 3.4. Trends – By Vaccine Type, By Application, By End-user, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Aquaculture Vaccines Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Bacterial Vaccines
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Viral Vaccines
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Parasitic Vaccines
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Fish
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Shrimp
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Mollusks
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Others
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Aquaculture Farms
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Veterinary Clinics
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Research Institutes.
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By End-user, and Region, 2024 - 2031
- 9.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Bacterial Vaccines
- 9.1.2 Viral Vaccines
- 9.1.3 Parasitic Vaccines
- 9.2.1 Fish
- 9.2.2 Shrimp
- 9.2.3 Mollusks
- 9.2.4 Others
- 9.3.1 Aquaculture Farms
- 9.3.2 Veterinary Clinics
- 9.3.3 Research Institutes.
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Aquaculture Vaccines Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Bacterial Vaccines
- 10.1.2 Viral Vaccines
- 10.1.3 Parasitic Vaccines
- 10.2.1 Fish
- 10.2.2 Shrimp
- 10.2.3 Mollusks
- 10.2.4 Others
- 10.3.1 Aquaculture Farms
- 10.3.2 Veterinary Clinics
- 10.3.3 Research Institutes.
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Aquaculture Vaccines Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Bacterial Vaccines
- 11.1.2 Viral Vaccines
- 11.1.3 Parasitic Vaccines
- 11.2.1 Fish
- 11.2.2 Shrimp
- 11.2.3 Mollusks
- 11.2.4 Others
- 11.3.1 Aquaculture Farms
- 11.3.2 Veterinary Clinics
- 11.3.3 Research Institutes.
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Aquaculture Vaccines Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Bacterial Vaccines
- 12.1.2 Viral Vaccines
- 12.1.3 Parasitic Vaccines
- 12.2.1 Fish
- 12.2.2 Shrimp
- 12.2.3 Mollusks
- 12.2.4 Others
- 12.3.1 Aquaculture Farms
- 12.3.2 Veterinary Clinics
- 12.3.3 Research Institutes.
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Aquaculture Vaccines Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Bacterial Vaccines
- 13.1.2 Viral Vaccines
- 13.1.3 Parasitic Vaccines
- 13.2.1 Fish
- 13.2.2 Shrimp
- 13.2.3 Mollusks
- 13.2.4 Others
- 13.3.1 Aquaculture Farms
- 13.3.2 Veterinary Clinics
- 13.3.3 Research Institutes.
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Aquaculture Vaccines Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Aquaculture Vaccines Market – Zoetis Inc.
- 14.2.2 Merck & Co. Inc.
- 14.2.3 Elanco Animal Health
- 14.2.4 Virbac
- 14.2.5 HIPRA
- 14.2.6 Phibro Animal Health Corporation
- 14.2.7 Benchmark Holdings plc
- 14.2.8 Kyoritsu Seiyaku Corporation
- 14.2.9 Vaxxinova International BV
- 14.2.10 IDT Biologika GmbH.
16. Principal Presumptions and Acronyms